Delivery Order SPE2DB20D2104-SPE2DB25FMXVX
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $4,248.51 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-tablet supply) on September 4, 2025, with completion scheduled for September 5, 2025. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $3,580.26. This non-competitive delivery order is expected to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.43 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carried no set-aside designation, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under a larger Indefinite Delivery Contract vehicle. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,386.80 by the Defense Logistics Agency's Medical Supply Chain on July 15, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 16, 2025. The award is...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1-20 Tablet in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $1,790.10 and an ultimate completion date of August 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at...
- The Defense Logistics Agency awarded a delivery order valued at $2,898.32 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract...